AB Soft ii manual Ref Type Report

Page 9

clinical trials: IMMPACT recommendations. J Pain 9(2): 105-121, 2/2008.

Food and Drug Administration. Guidelines for Industry (draft). Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2006. Rockville MD, U.S. Department of Health and Human Services.

Ref Type: Report

Klepstad P, Loge JH, Borchgrevink PC, Mendoza TR, Cleeland CS, Kaasa S. The Norwegian Brief Pain Inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage 24(5): 517-525, 11/2002.

Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1(3): 277-299, 9/1975.

Melzack R, Casey KL. Sensory, motivational, and central control determinants of pain: a new conceptual model. In: Kenshalo DR, editor. The Skin Senses Proceedings. Springfield IL: Thomas; pp. 423-439, 1968.

Mendoza T, Mayne T, Rublee D, Cleeland C. Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain 10(4): 353-361, 5/2006.

Mendoza TR, Chen C, Brugger A, Hubbard R, Snabes M, Palmer SN, Zhang Q, Cleeland CS. The utility and validity of the modified Brief Pain Inventory in a multiple-dose postoperative analgesic trial. Clin J Pain 20(5): 357-362, 9/2004.

Radbruch L, Loick G, Kiencke P, Lindena G, Sabatowski R, Grond S, Lehmann KA, Cleeland CS. Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage 18(3): 180- 187, 9/1999.

Saxena A, Mendoza T, Cleeland CS. The assessment of cancer pain in north India: the validation of the Hindi Brief Pain Inventory--BPI-H. J Pain Symptom Manage 17(1): 27-41, 1/1999.

Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland CS, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson

JP, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Witter J. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 106: 337-345, 2003.

Turk DC, Dworkin RH, Burke LB, Gershon R, Rothman M, Scott J, Allen RR, Atkinson JH, Chandler J, Cleeland C, Cowan P, Dimitrova R, Dionne R, Farrar JT, Haythornthwaite JA, Hertz S, Jadad AR, Jensen MP, Kellstein D, Kerns RD, Manning DC, Martin S, Max MB, McDermott MP, McGrath P, Moulin DE, Nurmikko T, Quessy S, Raja S, Rappaport BA, Rauschkolb C, Robinson JP, Royal MA, Simon L, Stauffer JW, Stucki G, Tollett J, von ST, Wallace MS, Wernicke J, White RE, Williams AC, Witter J, Wyrwich KW. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain 125(3): 208-215, 12/2006.

13

14

Image 9
Contents Brief Pain Inventory Copyright and Terms of Use Table of Contents Developing a Measurement Model and Items BackgroundTest Construction Standards Brief Pain Inventory Early Version The Wisconsin Brief Pain QuestionnaireScoring the Brief Pain Inventory as an Outcome Measure Test-Retest Reliability 19, 1/2005 ReferencesRef Type Report Cancer Bone Pain BPI References Use of the BPI in Various StudiesPage Cancer Epidemiology Cancer Pain Page Page Page Page Fabry Disease Depressive DisordersHIV/AIDS FibromyalgiaNeuromuscular Pain Minority StudiesPage Neuropathic Pain Osteoarthritis and Other Joint Diseases Page Surgical and Procedural Pain Psychosocial StudiesPage Validation Studies Page Page Page Language Translations Methods Papers Page Page